Status:
COMPLETED
Baduanjin on Patients With Schizophrenia
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
National Taiwan University
Conditions:
Schizophrenia
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
As an ancient, popular Chinese exercise, Baduanjin is characterized by symmetrical posture, deep breathing and meditation and easy to learn. Previous studies showed immediate effect of Baduanjin on co...
Detailed Description
A single-blind, 2-arm randomized controlled trial investigating the benefits of Baduanjin exercise on middle-aged and older patients with schizophrenia. A total of 48 participants will be assigned to ...
Eligibility Criteria
Inclusion
- Having a diagnosis of schizophrenia according to the DSM-5.
- Independent adult aged 40 years or older in the day-care center.
- Having a stable mental status without shift in medication and keep in same dose for at least one month.
Exclusion
- Serious physical conditions that will impede participation, such as cardiovascular disease, musculoskeletal disease or pulmonary system disease.
- Visual or auditory impairment that precludes completion of assessment.
- Acute psychosis requiring hospitalization.
- Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.
- Participating in another clinical trial at the same time.
Key Trial Info
Start Date :
April 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04430309
Start Date
April 10 2021
End Date
June 30 2022
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Kaohsiung Medical Center
Kaohsiung City, Taiwan, 833